Skip to main content

Assessment of some inflammatory markers and lipid profile as risk factors for atherosclerosis in subclinical hypothyroid patients

Abstract

Background

Subclinical hypothyroidism (SCH) is associated with dyslipidemia and low grade inflammation leading to atherosclerosis. Atherosclerosis shows an association with inflammatory markers, which with dyslipidemia may accelerate the atherogenesis, in SCH.

Objective

The objective of this study was to investigate some inflammatory markers and lipid profile as risk factors for atherosclerosis in SCH.

Patients and methods

An overall 100 participants were included and classified into two groups: control group I included 20 healthy volunteer, patient group II included 80 SCH patients and was subdivided into group IIa (26 male patients) and group IIb (54 female patients). All patients were submitted to the following investigations: complete blood picture, liver function tests, renal function tests, Lipid profile, calculated risk ratio I and II and specific laboratory Investigations [thyroid-stimulating hormone (TSH), free thyroxine, free tri-iodothyronine, C-reactive protein (CRP), serum interleukin (IL)-6 and serum IL-10 assays].

Results

There were statistically high significant differences between the control group and the SCH group as regards serum triglycerides, cholesterol, low-density lipoprotein, risk ratio I and II, TSH, IL-6, IL-10 and CRP (P<0.001). Statistically significant higher levels of CRP, serum IL-6 and IL-10 were observed in SCH patients than in controls. TSH had a positive correlation in SCH patients with all studied parameters including all lipid parameters, CRP, IL-6 and IL-10 and was negative only to free tri-iodothyronine and free thyroxine, whereas IL-6 and IL-10 correlated also with all parameters except age.

Conclusion

SCH is associated with increased levels of inflammatory markers and dyslipidemia, which are indicators for atherosclerosis, and are good predictors of cardiovascular morbidity.

References

  1. Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ 2014; 349:4929.

    Article  Google Scholar 

  2. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32:2045–2051.

    Article  CAS  Google Scholar 

  3. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005; 3:1618–1627.

    Article  CAS  Google Scholar 

  4. Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003; 108:81–85.

    Google Scholar 

  5. Yu YT, Ho CT, Hsu HS, Li CI, Davidson LE, Liu CS, et al. Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese. Endocrine 2013; 44:716–722.

    Article  CAS  Google Scholar 

  6. Shekhar R, Chowdary NVS, Das MC, Vidya D, Prabodh S. Prevalence of subclinical hypothyroidism in costal region of Andhra Pradesh. Biomed Res 2011; 22:471–474.

    CAS  Google Scholar 

  7. Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs 2012; 72:17–33.

    Article  CAS  Google Scholar 

  8. Gill DS, Fonseca VA, Barradas MA. Laboratory assessment of blood urea concentration. J Clin Path 1986; 44:234–237.

    Google Scholar 

  9. Otsujis Shibata H, Umeda M. Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 1982; 28:i2121–i2124.

    Article  Google Scholar 

  10. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: increased release of interleukin-6 and interleukin-10. QJM 1997; 90:19–25.

    Article  CAS  Google Scholar 

  11. Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F. Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003; 120:99–103.

    Article  Google Scholar 

  12. Hennessey JV, Espaillat R. Subclinical hypothyroidism: a historical view and shifting prevalence. Int J Clin Pract 2015; 69:771–782.

    Article  CAS  Google Scholar 

  13. Alibaz Oner F, Yurdakul S, Oner E, Kubat Uzum A, Erguney M. Evaluation of the effect of l-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism. Endocrine 2011; 40:280–284.

    Article  Google Scholar 

  14. Gao CX, Yang B, Guo Q, Wei LH, Tian LM. High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism. Horm Metab Res 2015; 47:220–224.

    CAS  PubMed  Google Scholar 

  15. Karoli R, Fatima J, Shukla V, Chandra A, Khanduri S, Rawat A. Hospital based study of carotid intima media thickness and high sensitivity C-reactive protein in young hypothyroid patients. J Indian Acad Clin Med 2014; 15:116–119.

    Google Scholar 

  16. Lu M, Yang CB, Gao L, Zhao JJ. Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review). Exp Ther Med 2015; 9:3–10.

    Article  CAS  Google Scholar 

  17. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Shirakawa K, Yamada S, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006; 91:154–158.

    Article  CAS  Google Scholar 

  18. McAninch EA, Bianco AC. The history and future of treatment of hypothyroidism. Ann Intern Med 2016; 164:50–56.

    Article  Google Scholar 

  19. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol 2004; 44:1636–1640.

    Article  Google Scholar 

  20. Cabral MD, Teixeira PF, Silva NA, Morais FF, Soares DV, Salles E, et al. Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. Braz J Med Biol Res 2009; 42:426–432.

    Article  CAS  Google Scholar 

  21. Celik C, Abali R, Tasdemir N, Guzel S, Yuksel A, Aksu E, et al. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?. Gynecol Endocrinol 2012; 28:615–618.

    Article  CAS  Google Scholar 

  22. Marwaha RK, Tandon N, Garg MK, Kanwar R, Sastry A, Narang A, et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin Biochem 2011; 44:1214–1217.

    Article  CAS  Google Scholar 

  23. Türemen EE, Çetinarslan B, Şahin T, Cantürk Z, Tarkun I. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 2011; 58:349–354.

    Article  Google Scholar 

  24. Roy S, Banerjee U, Dasgupta A. Effect of sub clinical hypothyroidism on C-reactive protein and ischemia modified albumin. Mymensingh Med J 2015; 24:379–384.

    CAS  PubMed  Google Scholar 

  25. Elshenawy SZ, Hemi MH, Attia H. Serum levels of pro-inflammatory cytokines (interleukin 6 and interleukin 15) and adiponectin in hashimoto’s thyroiditis with different thyroid function states. J Am Sci 2011; 7:1156–1162.

    Google Scholar 

  26. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2006; 91:5076–5082.

    Article  CAS  Google Scholar 

  27. Oktay B, Ferda B, Mehmet C, Ozlem G, Arif Y. Comparison of pre- and post-levothyroxine high-sensitivity C-reactive protein and fetuin-A level in subclinical hypothyroidism. Clinics (Sao Paulo) 2015; 70:97–101.

    Article  Google Scholar 

  28. Nielsen CH, Brix TH, Leslie RG, Hegedüs L. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase. Clin Immunol 2009; 133:218–227.

    Article  CAS  Google Scholar 

  29. Dardano A, Monzani F. Recombinant human TSH acutely impairs endothelium-dependent vasodilation. Eur J Endocrinol 2007; 157:367–369.

    Article  CAS  Google Scholar 

  30. La-Vignera S, Condorelli R, Vicari E, Calogero AE. Endothelial dysfunction and subclinical hypothyroidism: a brief review. J Endocrinol Invest 2012; 35:96–103.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Khaled A. El-Hefnawy MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Hefnawy, K.A., Elsaid, H.H. Assessment of some inflammatory markers and lipid profile as risk factors for atherosclerosis in subclinical hypothyroid patients. Egypt J Intern Med 31, 115–121 (2019). https://doi.org/10.4103/ejim.ejim_94_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_94_18

Keywords